Teva EVP Business Development Evan Lippman sells 18,600 shares for $680,291.28
TEVA•Teva executive sells shares
- Teva EVP, Business Development Evan Lippman sold 18,600 ordinary shares on Aug. 17, 2026.
- Shares sold at a weighted average price of $36.57.
- Direct holdings fell to 25,591 ordinary shares following the sale.
